SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882104-20-000213
Filing Date
2020-12-22
Accepted
2020-12-22 19:51:33
Documents
1
Period of Report
2020-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160868467873868.html 4  
1 FORM 4 wf-form4_160868467873868.xml 4 4452
  Complete submission text file 0000882104-20-000213.txt   5946
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
MCLAUGHLIN JOHN PETER (Reporting) CIK: 0001277967 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 201409471